Evidence map›Paper›PMID 23152325›Full record

ReviewScience translational medicine2012

Building vascular networks.

Hojae Bae, Amey S Puranik, Robert Gauvin, Faramarz Edalat, Brenda Carrillo-Conde, Nicholas A Peppas, Ali Khademhosseini

Abstract readReview
In one paragraph

Review in Science translational medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. [Application and progress of bio-derived materials in bladder regeneration and repair].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Materials today. Bio · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Generation of a Perfusable 3D Lung Cancer Model by Digital Light Processing.International journal of molecular sciences · 2023
    Article
  18. Regenerative biomaterials · 2023
    Review
  19. Article
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hojae BaeDepartment of Maxillofacial Biomedical Engineering and Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea.
Amey S Puranik
Robert Gauvin
Faramarz Edalat
Brenda Carrillo-Conde
Nicholas A Peppas
Ali Khademhosseini

Funding

TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CRISTINI, VITTORIO · 2009 to 2014
$10.8M
Microengineered Osteons for Bone Tissue EngineeringR01AR057837 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2010 to 2018
$5.1M
pH Sensitive Complex Hydrogels for Protein Drug ReleaseR01EB000246 · NIBIB · UNIVERSITY OF TEXAS AUSTIN · PI LOWMAN, ANTHONY M, PEPPAS, NICHOLAS A · 2002 to 2014
$3.8M
3D combinatorial microenvironments for effective cell based therapyR01HL099073 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI, LIAO, RONGLIH · 2010 to 2013
$2.6M
Microfabricated Vascularized 3D Tissue Engineered ConstructsR01HL092836 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI · 2008 to 2012
$2.4M
Engineering Vascularized Bone Tissues By Microfabrication And ScaffoldingR01DE021468 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2011 to 2014
$1.8M
A Microfabrication Platform for Direct Printing Vascularized Functional Tissue CoR01EB012597 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN · 2010 to 2013
$1.4M
PH-SENSITIVE HYDROGELS FOR DRUG RELEASER01GM043337 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI PEPPAS, NICHOLAS A · 1990 to 2001
$590k
Thermally Responsive Magnetic-Hydrogel Nanocomposites for Advanced Drug DeliveryR21EB012726 · NIBIB · UNIVERSITY OF TEXAS AT AUSTIN · PI PEPPAS, NICHOLAS A · 2011 to 2012
$393k
NCI NIH HHS U54 CA143837NCI NIH HHS U54-CA-143837NHLBI NIH HHS HL092836NHLBI NIH HHS HL099073NHLBI NIH HHS R01 HL092836NHLBI NIH HHS R01 HL099073NIAMS NIH HHS R01 AR057837NIBIB NIH HHS EB012597NIBIB NIH HHS EB012726NIBIB NIH HHS EB024618NIBIB NIH HHS R01 EB000246NIBIB NIH HHS R01 EB012597NIBIB NIH HHS R21 EB012726NIDCR NIH HHS DE021468NIDCR NIH HHS R01 DE021468NIGMS NIH HHS R01 GM043337
6 · The paper itself

Abstract

Only a few engineered tissues-skin, cartilage, bladder-have achieved clinical success, and biomaterials designed to replace more complex organs are still far from commercial availability. This gap exists in part because biomaterials lack a vascular network to transfer the oxygen and nutrients necessary for survival and integration after transplantation. Thus, generation of a functional vasculature is essential to the clinical success of engineered tissue constructs and remains a key challenge for regenerative medicine. In this Perspective, we discuss recent advances in vascularization of biomaterials through the use of biochemical modification, exogenous cells, or microengineering technology.

Indexed as

AnimalsBiocompatible MaterialsBlood VesselsHumansMiceNeovascularization, PhysiologicRegenerative MedicineTissue EngineeringTissue ScaffoldsBiocompatible Materials

Identifiers

PMID23152325
PMCPMC3569029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.